EX-1 2 a16-17495_1ex1.htm EX-1

Exhibit 1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $.0001 per share, of Momenta Pharmaceuticals, Inc., a Delaware corporation.

DATE: August 30, 2016
	NOVARTIS AG
	By:	/s/ Christian Rehm
		Name: Christian Rehm
		Title: Authorized Signatory
	By:	/s/ Katja Roth Pellanda
		Name: Katja Roth Pellanda
		Title: Authorized Signatory
	NOVARTIS PHARMA AG
	By:	/s/ Jean-Baptiste Emery
		Name: Jean-Baptiste Emery
		Title: Authorized Signatory
	By:	/s/ Felix Eichhorn
		Name: Felix Eichhorn
		Title: Authorized Signatory